Xylocaine injectable anesthetic recalled for temperature abuse during manufacturing
McKesson Medical-Surgical is recalling Xylocaine injectable vials nationwide due to temperature abuse during manufacturing and distribution. This local anesthetic is used for medical and dental procedures.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The temperature abuse could potentially affect drug stability and sterility, but no adverse outcomes have been reported. Per the rubric, recalls involving risk-of-harm products without reported injuries are classified as High.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Xylocaine (lidocaine hydrochloride 1% with epinephrine bitartrate) multi-dose vials due to cGMP deviations involving temperature abuse. The recalled product consists of 76 trays containing 25 vials each and was distributed nationwide to healthcare facilities and medical and dental providers. Temperature abuse could compromise the sterility, stability, and potency of this injectable anesthetic.
Xylocaine is used for local anesthesia via infiltration and perineural (nerve block) procedures in medical, surgical, and dental settings. Healthcare facilities should review their records using the dates provided in notification letters sent by McKesson. Because the firm cannot identify specific lot numbers by customer, each notification includes the date product was distributed and the dates when affected product may have been shipped. Facilities with potentially affected product should quarantine it and contact McKesson or their supplier for further instructions.
The recalled product
- Product
- XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE)
- Brand
- XYLOCAINE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Anesthetic
- Hazard
- temperature-exposure
- stability-loss
- sterility-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (14)
- 0363323484576
- 0363323485016
- 0363323483036
- 0363323487072
- 0363323486013
- 0363323495091
- 0363323488079
- 0363323489021
- 0363323495046
- 0363323491017
- 0363323492045
- 0363323492090
- 0363323482015
- 0363323481018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · XYLOCAINE
- HighDental anesthetic injection recalled for defective cartridge containers
FDA (Drugs) · 2025-12-24
- HighXylocaine Lidocaine Injectable Anesthetic Recalled for Storage Temperature Abuse
FDA (Drugs) · 2022-06-15
- ModerateXylocaine Lidocaine Injection Recalled for Low Epinephrine Assay Results
FDA (Drugs) · 2021-07-14
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27